ES2140215T3 - Metodos para inhibir la exportacion de proteinas sin secuencia conductora que emplean glicosidos cardiacos o agliconas de los mismos y derivados. - Google Patents
Metodos para inhibir la exportacion de proteinas sin secuencia conductora que emplean glicosidos cardiacos o agliconas de los mismos y derivados.Info
- Publication number
- ES2140215T3 ES2140215T3 ES97906577T ES97906577T ES2140215T3 ES 2140215 T3 ES2140215 T3 ES 2140215T3 ES 97906577 T ES97906577 T ES 97906577T ES 97906577 T ES97906577 T ES 97906577T ES 2140215 T3 ES2140215 T3 ES 2140215T3
- Authority
- ES
- Spain
- Prior art keywords
- methods
- export
- aglicones
- proteins
- inhibit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
LA INVENCION PROPORCIONA METODOS PARA INHIBIR LA EXPORTACION DE UNA PROTEINA SIN LIDER A PARTIR DE UNA CELULA PONIENDO EN CONTACTO LA CELULA CON UN GLICOSIDO CARDIACO O DERIVADO AGLICON. LAS PROTEINAS SIN LIDER INCLUYEN FGF-1, FGF-2, IL-1 AL}, IL-1 BE} Y FACTOR XIIIA. ESTOS METODOS SON UTILES EN EL TRATAMIENTO DE DIFERENTES ESTADOS, INCLUYENDO TUMORES Y DIABETES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/599,895 US5891855A (en) | 1996-02-12 | 1996-02-12 | Inhibitors of leaderless protein export |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2140215T3 true ES2140215T3 (es) | 2000-02-16 |
Family
ID=24401543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97906577T Expired - Lifetime ES2140215T3 (es) | 1996-02-12 | 1997-02-12 | Metodos para inhibir la exportacion de proteinas sin secuencia conductora que emplean glicosidos cardiacos o agliconas de los mismos y derivados. |
Country Status (9)
Country | Link |
---|---|
US (4) | US5891855A (es) |
EP (2) | EP0828497B1 (es) |
JP (1) | JPH11500454A (es) |
AT (1) | ATE183922T1 (es) |
AU (1) | AU706644B2 (es) |
CA (1) | CA2242245A1 (es) |
DE (1) | DE69700464T2 (es) |
ES (1) | ES2140215T3 (es) |
WO (1) | WO1997028808A1 (es) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6306613B1 (en) | 1997-02-26 | 2001-10-23 | Ciblex Corporation | Modulators of leaderless protein export and methods for identifying and using the same |
US6083706A (en) * | 1997-02-26 | 2000-07-04 | Ciblex Corporation | Inhibitors of leaderless protein export |
US5910484A (en) * | 1997-05-30 | 1999-06-08 | The General Hospital Corporation | Treatment of ischemic cardiac malfunction |
GB9716273D0 (en) | 1997-07-31 | 1997-10-08 | Kimberly Clark Ltd | Hand cleanser |
GB9725480D0 (en) * | 1997-12-01 | 1998-01-28 | Univ London | Cytokines and their use in the treatment of established chronic infections and cancers |
AUPP249298A0 (en) * | 1998-03-20 | 1998-04-23 | Ag-Gene Australia Limited | Synthetic genes and genetic constructs comprising same I |
KR20010042069A (ko) * | 1998-03-20 | 2001-05-25 | 베니텍 오스트레일리아 리미티드 | 유전자 발현 조절방법 |
EP1150687A2 (en) | 1999-02-12 | 2001-11-07 | Cellpath, Inc. | Methods for anti-tumor therapy |
KR20070118315A (ko) * | 1999-04-21 | 2007-12-14 | 와이어쓰 | 폴리뉴클레오티드 서열의 기능을 억제하기 위한 조성물 |
US6423885B1 (en) | 1999-08-13 | 2002-07-23 | Commonwealth Scientific And Industrial Research Organization (Csiro) | Methods for obtaining modified phenotypes in plant cells |
IL138529A0 (en) * | 2000-09-18 | 2003-09-17 | Yeda Res & Dev | High level expression of heterologous proteins |
CA2445889A1 (en) * | 2001-05-02 | 2002-11-07 | University Of South Florida | Vector system for selection of genes encoding secreted proteins and membrane-bound proteins |
US20040082521A1 (en) * | 2002-03-29 | 2004-04-29 | Azaya Therapeutics Inc. | Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases |
EP1513403B1 (en) * | 2002-05-28 | 2017-02-15 | Bette Pollard | Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders |
US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
US7560528B2 (en) * | 2003-06-20 | 2009-07-14 | Efthimios Ippikoglou | Method of producing recombinant DNA molecules |
WO2005060951A2 (en) * | 2003-12-19 | 2005-07-07 | Bionaut Pharmaceuticals, Inc. | Anti-neoplastic agents, combination therapies and related methods |
DE102004036047A1 (de) * | 2004-07-24 | 2006-02-23 | Bioghurt Biogarde Gmbh & Co. Kg | Physiologisch aktive Zusammensetzung |
EP1789090A2 (en) * | 2004-09-02 | 2007-05-30 | Bionaut Pharmaceuticals, Inc. | Combinatorial chemotherapy treatment using na+/k+-atpase inhibitors |
US20080027010A1 (en) * | 2004-09-02 | 2008-01-31 | Bionaut Pharmaceuticals, Inc. | Treatment of refractory cancers using Na+/K+-ATPase inhibitors |
US20060135468A1 (en) | 2004-09-02 | 2006-06-22 | Bionaut Pharmaceuticals, Inc. | Treatment of refractory cancers using NA+/K+ ATPase inhibitors |
ATE509630T1 (de) * | 2004-09-02 | 2011-06-15 | Bionaut Pharmaceuticals Inc | Pankreaskrebsbehandlung mit na+/k+-atpase-hemmern |
US20070105790A1 (en) * | 2004-09-02 | 2007-05-10 | Bionaut Pharmaceuticals, Inc. | Pancreatic cancer treatment using Na+/K+ ATPase inhibitors |
EP1812010A2 (en) * | 2004-10-18 | 2007-08-01 | BTG International Limited | Use of na+/ k+-atpase inhibitors and antagonists thereof |
US20060205679A1 (en) * | 2004-10-22 | 2006-09-14 | Azaya Therapeutics, Inc. | Topical and oral formulations of cardiac glycosides for treating skin diseases |
JP5484735B2 (ja) * | 2006-01-31 | 2014-05-07 | ザ、ユニバーシティー、オブ、トレド | Na/K−ATPアーゼリガンド |
CN107235980A (zh) | 2006-05-04 | 2017-10-10 | 勃林格殷格翰国际有限公司 | 多晶型 |
EP1852108A1 (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
PE20080251A1 (es) * | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
US8283441B2 (en) | 2006-10-31 | 2012-10-09 | University Of Toledo | Na+K+-ATPase-specific peptide inhibitors/activators of SRC and SRC family kinases |
WO2009064657A1 (en) * | 2007-11-13 | 2009-05-22 | Phoenix Biotechnology Inc. | Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside |
AR071175A1 (es) | 2008-04-03 | 2010-06-02 | Boehringer Ingelheim Int | Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante |
KR101717301B1 (ko) * | 2008-10-14 | 2017-03-16 | 네리엄 바이오테크놀로지, 인크. | 강심 배당체의 추출방법 및 조성물 |
US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
CN102573469B (zh) | 2009-09-16 | 2015-02-25 | 托莱多大学 | Na/K-ATP酶配体、毒毛花苷G拮抗剂及其测试方法和用途 |
WO2011088208A1 (en) | 2010-01-13 | 2011-07-21 | The University Of Toledo | Materials and methods related to sodium/potassium adenosine triphosphase and cholesterol |
ES2654584T3 (es) | 2010-01-15 | 2018-02-14 | Suzhou Neupharma Co., Ltd | Ciertas entidades químicas, composiciones y métodos |
US8435525B1 (en) | 2010-04-16 | 2013-05-07 | Andrew B. Bush | FGF modulation of in vivo antibody production and humoral immunity |
US9226960B2 (en) | 2010-04-16 | 2016-01-05 | Andrew B. Bush | FGF modulation of in vivo antibody production and humoral immunity |
US9034883B2 (en) | 2010-11-15 | 2015-05-19 | Boehringer Ingelheim International Gmbh | Vasoprotective and cardioprotective antidiabetic therapy |
EP2670763B1 (en) | 2011-02-02 | 2018-08-01 | Suzhou Neupharma Co., Ltd | Certain chemical entities, compositions, and methods |
CN102219821A (zh) * | 2011-05-05 | 2011-10-19 | 沈阳药科大学 | 一类强心苷类化合物及其抗肿瘤用途 |
WO2013165924A1 (en) * | 2012-04-29 | 2013-11-07 | Neupharma, Inc. | Certain chemical entities, compositions, and methods |
WO2013169793A2 (en) * | 2012-05-09 | 2013-11-14 | Ipierian, Inc. | Methods and compositions for tdp-43 proteinopathies |
WO2013171167A1 (en) | 2012-05-14 | 2013-11-21 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome |
US9561245B2 (en) | 2012-09-06 | 2017-02-07 | The Board Of Regents Of The University Of Texas System | Combination treatments for melanoma |
US9572828B2 (en) | 2013-07-18 | 2017-02-21 | The Board Of Regents Of The University Of Texas System | Treatment for melanoma |
WO2017211979A1 (en) | 2016-06-10 | 2017-12-14 | Boehringer Ingelheim International Gmbh | Combinations of linagliptin and metformin |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5872103A (en) * | 1986-11-26 | 1999-02-16 | Belletti; Dino A. | Prevention of mammary tumors by treatment with cardiac glycosides |
US5545623A (en) * | 1994-06-10 | 1996-08-13 | Akira Matsumori | Method of inhibiting secretion of inflammatory cytokines |
US5556963A (en) | 1994-08-05 | 1996-09-17 | Oklahoma Medical Research Foundation | Synthesis of 4-alkoxy-N-acetylneuraminic acid |
WO1996004921A1 (en) * | 1994-08-13 | 1996-02-22 | Hong Keun Chung | TNFα-SECRETION INHIBITOR CONTAINING SYRINGIN OR ITS AGLYCONE |
US5627195A (en) * | 1995-04-11 | 1997-05-06 | Massachusetts Eye And Ear Infirmary | Treatment for ocular inflammation |
-
1996
- 1996-02-12 US US08/599,895 patent/US5891855A/en not_active Expired - Fee Related
-
1997
- 1997-02-12 EP EP97906577A patent/EP0828497B1/en not_active Expired - Lifetime
- 1997-02-12 DE DE69700464T patent/DE69700464T2/de not_active Expired - Fee Related
- 1997-02-12 AU AU21231/97A patent/AU706644B2/en not_active Ceased
- 1997-02-12 AT AT97906577T patent/ATE183922T1/de not_active IP Right Cessation
- 1997-02-12 ES ES97906577T patent/ES2140215T3/es not_active Expired - Lifetime
- 1997-02-12 JP JP9528759A patent/JPH11500454A/ja active Pending
- 1997-02-12 EP EP99100073A patent/EP0941733A3/en not_active Withdrawn
- 1997-02-12 WO PCT/US1997/002237 patent/WO1997028808A1/en active IP Right Grant
- 1997-02-12 CA CA002242245A patent/CA2242245A1/en not_active Abandoned
-
1998
- 1998-12-14 US US09/211,290 patent/US6071885A/en not_active Expired - Fee Related
-
1999
- 1999-05-28 US US09/322,676 patent/US6107283A/en not_active Expired - Fee Related
- 1999-12-17 US US09/466,036 patent/US6281197B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69700464T2 (de) | 2000-04-06 |
US6281197B1 (en) | 2001-08-28 |
EP0828497A1 (en) | 1998-03-18 |
JPH11500454A (ja) | 1999-01-12 |
US6107283A (en) | 2000-08-22 |
US5891855A (en) | 1999-04-06 |
EP0828497B1 (en) | 1999-09-01 |
CA2242245A1 (en) | 1997-08-14 |
ATE183922T1 (de) | 1999-09-15 |
AU2123197A (en) | 1997-08-28 |
EP0941733A3 (en) | 1999-12-01 |
WO1997028808A1 (en) | 1997-08-14 |
DE69700464D1 (de) | 1999-10-07 |
AU706644B2 (en) | 1999-06-17 |
EP0941733A2 (en) | 1999-09-15 |
US6071885A (en) | 2000-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2140215T3 (es) | Metodos para inhibir la exportacion de proteinas sin secuencia conductora que emplean glicosidos cardiacos o agliconas de los mismos y derivados. | |
IT1225701B (it) | Poltrona per abbronzatura | |
FI911326A0 (fi) | Manipulering eller skada indikerande organ. | |
KR880700670A (ko) | 알파-msh의 동족체의 국소적용으로 메라노싸이트를 자극시키는 방법 및 이에 사용될 수 있는 조성물 | |
DK130388D0 (da) | Olie-i-vand-emulsioner, deres fremstilling og anvendelse | |
TR23582A (tr) | Ters akista yikama yapmaya mahsus birden fazla kademeli duezen ve bu duezene ait usul kademeleri | |
IT8921737A0 (it) | Struttura di vela cosidetta ad ala. | |
ES2013631B3 (es) | Metodo para el tratamiento de tejidos. | |
NO874722D0 (no) | Forgrenede kvaternaere polyoksalkylenblandingspolyestere, fremgangsmaate til deres fremstilling og deres anvendelse. | |
BR8700779A (pt) | Derivado de 2-ciano-benzimidazol,composicao antifungica,processo para a preparacao e utilizacao do dito derivado,processo para o tratamento de vegetais,associacoes compreendendo tais derivados,utilizacao das ditas associacoes,composicao fungicida,processo para preparacao das ditas associacoes,compostos e derivados de anilina | |
NO901504L (no) | Isolerings- og fjaerelementer eller klemmelementer for festing av skinner. | |
FI920872A0 (fi) | Foerbaettringar i skyddshjaelmar eller i anslutning till dessa. | |
ES1008643Y (es) | Mueble expositor de muestras de tejidos. | |
DE3886851D1 (de) | Stroboskoplicht-Generator für insbesondere medizinische Zwecke. | |
DK95988A (da) | Synergistisk, veterinaert praeparat og/eller foderpraeblanding og fremgangsmaade til fremstilling heraf | |
NO872885L (no) | 1,3,5-tritianderivater og fremgangsmte for deres fremstilling. | |
DK538586A (da) | Substituerede pyrazolin-5-oner, deres fremstilling og anvendelse | |
IT8920984A0 (it) | Composizione per il trattamento della nevralgia erpetica acuta e la nevralgia post erpetica. | |
IT8840104A0 (it) | Cannula per prelievi, particolarmente di tipo endometriale e/o endocervicale | |
ES1009377Y (es) | Expositor perfeccionado para muestras cosmeticas. | |
IT214012Z2 (it) | Connettore perfezionato per basi tripolari e/o simili. | |
NO894379D0 (no) | Sammensetninger og fremgangsmaate for konservering eller farging av tre. | |
ES1008369Y (es) | Soporte perfeccionado para barra de cortinajes. | |
IT209892Z2 (it) | Apparecchio abbronzante con testa perfezionata. | |
DK517287A (da) | Proevebehandlingsenhed |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 828497 Country of ref document: ES |